202 related articles for article (PubMed ID: 20957693)
1. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.
Reynolds CF; Dew MA; Martire LM; Miller MD; Cyranowski JM; Lenze E; Whyte EM; Mulsant BH; Pollock BG; Karp JF; Gildengers A; Szanto K; Dombrovski AY; Andreescu C; Butters MA; Morse JQ; Houck PR; Bensasi S; Mazumdar S; Stack JA; Frank E
Int J Geriatr Psychiatry; 2010 Nov; 25(11):1134-41. PubMed ID: 20957693
[TBL] [Abstract][Full Text] [Related]
2. Anxiety impairs depression remission in partial responders during extended treatment in late-life.
Greenlee A; Karp JF; Dew MA; Houck P; Andreescu C; Reynolds CF
Depress Anxiety; 2010 May; 27(5):451-6. PubMed ID: 20186975
[TBL] [Abstract][Full Text] [Related]
3. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
[TBL] [Abstract][Full Text] [Related]
4. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
[TBL] [Abstract][Full Text] [Related]
5. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
6. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S
JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder.
Lam RW; Parikh SV; Ramasubbu R; Michalak EE; Tam EM; Axler A; Yatham LN; Kennedy SH; Manjunath CV
Br J Psychiatry; 2013 Nov; 203(5):358-65. PubMed ID: 24029535
[TBL] [Abstract][Full Text] [Related]
9. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression.
Frank E; Kupfer DJ; Buysse DJ; Swartz HA; Pilkonis PA; Houck PR; Rucci P; Novick DM; Grochocinski VJ; Stapf DM
Am J Psychiatry; 2007 May; 164(5):761-7. PubMed ID: 17475735
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination.
Rucci P; Frank E; Calugi S; Miniati M; Benvenuti A; Wallace M; Fagiolini A; Maggi L; Kupfer DJ; Cassano GB
Depress Anxiety; 2011 Nov; 28(11):955-62. PubMed ID: 21898715
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.
Möller HJ; Schnitker J; Flürenbrock W
Pharmacopsychiatry; 2010 Aug; 43(6):210-5. PubMed ID: 20589597
[TBL] [Abstract][Full Text] [Related]
14. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).
Frasure-Smith N; Koszycki D; Swenson JR; Baker B; van Zyl LT; Laliberté MA; Abramson BL; Lambert J; Gravel G; Lespérance F
Psychosom Med; 2006; 68(1):87-93. PubMed ID: 16449416
[TBL] [Abstract][Full Text] [Related]
15. Evidence based review of escitalopram in treating major depressive disorder in primary care.
Einarson TR
Int Clin Psychopharmacol; 2004 Sep; 19(5):305-10. PubMed ID: 15289704
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Bielski RJ; Ventura D; Chang CC
J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
[TBL] [Abstract][Full Text] [Related]
18. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
19. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
Lepola UM; Loft H; Reines EH
Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
